ATLASIDEXX Laboratories (IDXX) earnings date: Nov 2, 2026
IDEXX Laboratories (IDXX) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, before the open. Analysts expect EPS of $3.71.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IDXX
| Last price | $551.21 (-4.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.8% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the IDEXX Laboratories stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
IDEXX Laboratories reports on Nov 2, 2026. One email the day before, with ATLAS’s read on IDEXX Laboratories. You can switch it off at any time.
Alert me before IDXX reportsFree to start. Creating an account takes under a minute.
IDXX earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $3.71 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -75.4% |
| Average move around a report | ±5.5% (last 5) |
| Sector | Healthcare · Diagnostics & Research |
IDEXX Laboratories earnings history: last 5 reports
IDEXX Laboratories last reported on Aug 4, 2026: EPS of $4.27 against an estimate of $3.93 (+8.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | $3.93 | $4.27 | +8.7% | Beat | +3.0% |
| May 5, 2026 | $3.41 | $3.47 | +1.8% | In line | +2.9% |
| Feb 2, 2026 | $2.94 | $3.08 | +4.8% | Beat | -5.7% |
| Dec 5, 2025 | -$0.02 | -$0.10 | -400.0% | Miss | -1.5% |
| Nov 3, 2025 | $3.15 | $3.40 | +7.9% | Beat | +14.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IDXX
See the fair value, the probability range and the earnings history of IDEXX Laboratories on its ATLAS page.
IDEXX Laboratories (IDXX) stock analysisPlans from €3.99 a month.
IDEXX Laboratories earnings: frequently asked questions
When does IDEXX Laboratories (IDXX) report earnings?
IDEXX Laboratories is scheduled to report on Monday, November 2, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IDXX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $3.71 per share (USD). Estimates can change before the report.
How often does IDXX beat earnings estimates?
Of its last 5 reports with a recorded result, IDEXX Laboratories beat the EPS estimate 3 times; the average surprise was -75.4%. Past results do not predict the next one.
How much does IDXX move around earnings?
Over its last 5 reports the stock moved an average of 5.5% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did IDEXX Laboratories beat earnings estimates last quarter?
IDEXX Laboratories last reported on Aug 4, 2026: EPS of $4.27 against an estimate of $3.93 (+8.7% surprise), a beat.
How much does IDXX usually move in a day?
On a normal trading day the ATLAS model puts IDXX’s one-day range at about ±1.8%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer